Trend in the susceptibility of the most frequent bacterial pathogens isolated at Hospital General La Mancha Centro over 2010-2012 period;Tendencia de sensibilidad de los patógenos bacterianos más frecuentemente aislados en el Hospital General La Mancha Centro durante el periodo 2010-2012

Revista Espanola de Quimioterapia

Volumn 27, Issue 4, 2014, Pages 261-268

  Asencio Egea, María Ángeles ^a   Huertas, María ^a   Carranza, Rafael ^a   Franco, María ^a   Castellanos, Jesús ^a   Barberá, José Ramón ^a   del Carmen Conde, María ^b   Tenías, José María ^a  

^a HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

^b Hospital General La Mancha Centro   (Spain)

Author keywords

Antimicrobials; Bacterial pathogens; Nosocomial infections; Resistance

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; GLYCOPEPTIDE; LEVOFLOXACIN; LINEZOLID; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; ESCHERICHIA COLI; GENERAL HOSPITAL; HOSPITAL ADMISSION; HUMAN; KLEBSIELLA PNEUMONIAE; MEAN CORPUSCULAR HEMOGLOBIN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 84936994744     PISSN: 02143429     EISSN: 19889518     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Alvarez-Lerma F, Grau S. Management of antimicrobial use in the intensive care unit. Drugs 2012; 72:447-70.
2. Gould IM, David MZ, Esposito S, Garau J, Lina G, Mazzei T, et al. New insights into meticillin resistant Staphylococcus aureus pathogenesis, treatment and resistance. Int J Antimicrob Agents 2012; 39:96-104.
3. Peña C, Suarez C, Gozalo M, Murillas J, Almirante B, Pomar V, et al.; Spanish Network for Research in Infectious Diseases REIPI. Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections. Antimicrob Agents Chemother 2012; 56:1265-72.
4. Martínez-Martínez L, Calvo J. El problema creciente de la resistencia antibiótica en bacilos gramnegativos: situación actual. Enferm Infecc Microbiol Clin 2010; 28(Supl. 2):25-31.
5. Ho J, Tambyah PA, Paterson DL. Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis 2010; 23:546-53.
6. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2013. Disponible en: http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/database.aspx.
7. Livermore DL. Has the era of untreatable infections arrived? J Antimicrob Chemother 2009; 64 (Suppl. 1):i29-36.
8. John JF, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997; 24:471-85.
9. Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López-Fabal F, Gómez M; VIRA Study Group. Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance. Diagn Microbiol Infect Dis. 2011; 70:373-9.
10. van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 2012; 54:755-71.
11. Mensa J, Soriano A, Llinares P, Barberán J, Montejo M, Salavert M, et al. Guía de tratamiento antimicrobiano de la infección por Staphylococcus aureus. Rev Esp Quimioter 2013; 26 (Suppl. 1):1-84.
12. Tato M, Coque TM, Ruíz-Garbajosa P, Pintado V, Cobo J, Sader HS et al. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metalloβ-lactamase in Spain: toward endemicity? Clin Infect Dis 2007; 45: 1171-8.
13. Curiao T, Morosini MI, Ruiz-Garbajosa P, Robustillo A, Baquero F, Coque TM, et al. Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J Antimicrob Chemother 2010; 65: 1608-14.
14. Bouza E, García-Garrote F, Cercenado E, Marín M, Díaz MS, Sánchez Romero I, et al; Grupo Español para el estudio de Pseudomonas aeruginosa. Pseudomonas aeruginosa: estudio multicéntrico en 136 hospitales españoles. Rev Esp Quimioter 2003; 16:41-52.
15. Tacconelli E, Cataldo MA, Dancer SJ, de Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014; 20 (Suppl. 1):1-55.